continued from part 1 - Controller General of Patents, Designs, and ...

(12) PATENT APPLICATION PUBLICATION (21) Application No.6382/DELNP/2008 A
(19) INDIA
(22) Date of filing of Application :21/07/2008 (43) Publication Date : 24/10/2008
(54) Title of the invention : "USE OF DHA, EPA OR DHA-DERIVED ,EPA FOR TREATING A PATHOLOGY ASSOCIATED
WITH CELLULAR OXIDATIVE DAMAGE"
(51) International classification :A61K 31/202 (71)Name of Applicant :
(31) Priority Document No :P 2005 03202 1)BRUDY. TECHNOLOGY S.L.
(32) Priority Date :21/12/2005
Address of Applicant :RIERA DE SANT MIQUEL, 3, 2N
(33) Name of priority country :Spain
4A,08006 BARCELONA,SPAIN. Spain
(86) International Application No :PCT/EP2006/070016 (72)Name of Inventor :
Filing Date
:20/12/2006
1)JOHN CARLES DOMINGO PEDROL
(87) International Publication No :WO 2007/071733 2)JOSE ANTONIO VILLEGAS GARCIA
(61) Patent of Addition to Application
Number
Filing Date
:NA
:NA
(62) Divisional to Application Number :NA
Filing Date
:NA
(57) Abstract :
The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHAderived
EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for
the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with
oxidative damage to DNA and with physical exercise.
No. of Pages : 100 No. of Claims : 20
The Patent Office Journal 24/10/2008 25848